Cargando…

Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database

BACKGROUND: Few studies have examined the prescribing patterns of orexin receptor antagonists (ORAs) in the real-world clinical setting in Japan. OBJECTIVE: We sought to analyze the factors associated with ORA prescriptions for patients with insomnia in Japan. METHODS: Outpatients (aged ≥ 20 to <...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okuda, Shoki, Qureshi, Zaina P., Yanagida, Yukiko, Ito, Chie, Homma, Yuji, Tokita, Shigeru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982805/ https://www.ncbi.nlm.nih.gov/pubmed/36867350 http://dx.doi.org/10.1007/s40801-023-00356-4

Ejemplares similares

Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database
por: Okuda, Shoki, et al.
Publicado: (2023)

Demographic and clinical characteristics of patients with delirium: analysis of a nationwide Japanese medical database
por: Ueda, Naoya, et al.
Publicado: (2022)

Orexin receptor antagonists as therapeutic agents for insomnia
por: Equihua, Ana C., et al.
Publicado: (2013)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

Incremental medical cost of delirium in elderly patients with cognitive impairment: analysis of a nationwide administrative database in Japan
por: Igarashi, Masakazu, et al.
Publicado: (2022)

The clinical efficacy of orexin antagonists for primary insomnia- A review of the evidence
por: Vasiliu, O.
Publicado: (2023)

Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
por: Norman, Jessica L, et al.
Publicado: (2016)

Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
por: Roch, Catherine, et al.
Publicado: (2021)

Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review
por: Kishi, Taro, et al.
Publicado: (2021)

Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
por: Sarathi Chakraborty, Dwaipayan, et al.
Publicado: (2023)

Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis
por: Rocha, Rebeka Bustamante, et al.
Publicado: (2023)

Clinical characteristics and drug utilisation patterns in patients with chronic cough: a retrospective cohort study using a Japanese claims database
por: Arai, Yoko, et al.
Publicado: (2022)

Limited social support is associated with depression, anxiety, and insomnia in a Japanese working population
por: Omichi, Chie, et al.
Publicado: (2022)

Orexin Receptor Competitive Antagonists: A Novel target of the Sedative and hypnotics drugs for the pharmacotherapy of Insomnia
por: Banerjee, Indrajit
Publicado: (2018)

Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis
por: Xue, Tao, et al.
Publicado: (2023)

Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review
por: Besterman, Aaron D., et al.
Publicado: (2021)

Orexin, orexin receptor antagonists and central cardiovascular control
por: Carrive, Pascal
Publicado: (2013)

A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia
por: Ziemichód, Wojciech, et al.
Publicado: (2022)

Accidental ingestion of food allergens: A nationwide survey of Japanese nursery schools
por: Yanagida, Noriyuki, et al.
Publicado: (2019)

Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database
por: Kubota, Kiyoshi, et al.
Publicado: (2015)

Claims-Based Definition of Death in Japanese Claims Database: Validity and Implications
por: Ooba, Nobuhiro, et al.
Publicado: (2013)

Contact Dermatitis after Prescription of an Ophthalmic Ointment Containing Fradiomycin Sulfate: A Retrospective Database Study Using Japanese Health Insurance Claims Data
por: Sugimoto, Naomi, et al.
Publicado: (2017)

Analysis of nationwide hemophilia care: A cohort study using two Japanese healthcare claims databases
por: Kinai, Ei, et al.
Publicado: (2022)

The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System
por: Fragale, Jennifer E., et al.
Publicado: (2021)

Association between sleep disturbance in Alzheimer’s disease patients and burden on and health status of their caregivers
por: Okuda, Shoki, et al.
Publicado: (2019)

Insomnia and Depression: Japanese Hospital Workers Questionnaire Survey
por: Koyama, Fumihiko, et al.
Publicado: (2017)

Treatment strategy for insomnia disorder: Japanese expert consensus
por: Takaesu, Yoshikazu, et al.
Publicado: (2023)

Factors associated with high‐dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture
por: Takahashi, Tatsuichiro, et al.
Publicado: (2020)

Opportunities and perspectives for developing orexin receptor antagonists
por: Steiner, Michel A., et al.
Publicado: (2014)

Validity of diagnoses and procedures in Japanese dental claims data
por: Ono, Sachiko, et al.
Publicado: (2021)

Temporal trends of medical cost and cost-effectiveness in sepsis patients: a Japanese nationwide medical claims database
por: Oami, Takehiko, et al.
Publicado: (2022)

Disease trends after Helicobacter pylori eradication based on Japanese nationwide claims and the health check-up database
por: Mizukami, Kazuhiro, et al.
Publicado: (2023)

Targeting the Orexin System for Prescription Opioid Use Disorder
por: Matzeu, Alessandra, et al.
Publicado: (2020)

Increased prescriptions for irritable bowel syndrome after the 2018 Japan Floods: a longitudinal analysis based on the Japanese National Database of Health Insurance Claims and Specific Health Checkups
por: Okazaki, Yuji, et al.
Publicado: (2022)

Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
por: Yeoh, Jiann Wei, et al.
Publicado: (2014)

Nationwide claims database analysis of treatment patterns, costs and survival of Japanese patients with diffuse large B-cell lymphoma
por: Tsutsué, Saaya, et al.
Publicado: (2020)

A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia
por: Connor, Kathryn M., et al.
Publicado: (2016)

Population Pharmacokinetics and Exposure‐Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder
por: Lalovic, Bojan, et al.
Publicado: (2020)

Validation study on definition of cause of death in Japanese claims data
por: Ito, Fumiya, et al.
Publicado: (2023)

Changes in psychotropic polypharmacy and high‐potency prescription following policy change: Findings from a large scale Japanese claims database
por: Takeshima, Masahiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kmuoii2namm2f9oo7cg9cv487l